OpenURL Connection Search

Select item for more details and to access through your institution.

Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries.
Published in:
World Journal of Urology, 2021, v. 39, n. 2, p. 317, doi. 10.1007/s00345-019-03063-4
By:
- De Bruycker, Aurélie;
- Tran, Phuoc T.;
- Achtman, Ariel H.;
- Ost, Piet;
- GAP6 consortium;
- Boutros, Paul C.;
- Buzza, Mark;
- Corcoran, Niall M.;
- Dal Pra, Alan;
- Emmenegger, Urban;
- Fraser, Michael;
- Hovens, Chris M.;
- Koontz, Bridget F.;
- Lapointe, Jacques;
- Vela, Ian
Publication type:
Article
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
Published in:
World Journal of Urology, 2019, v. 37, n. 12, p. 2557, doi. 10.1007/s00345-018-2609-8
By:
- Dhondt, Bert;
- De Bleser, Elise;
- Claeys, Tom;
- Buelens, Sarah;
- Lumen, Nicolaas;
- Vandesompele, Jo;
- Beckers, Anneleen;
- Fonteyne, Valerie;
- Van der Eecken, Kim;
- De Bruycker, Aurélie;
- Paul, Jérôme;
- Gramme, Pierre;
- Ost, Piet
Publication type:
Article
A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer.
Published in:
Cancers, 2020, v. 12, n. 1, p. 132, doi. 10.3390/cancers12010132
By:
- De Bleser, Elise;
- Willems, Ruben;
- Decaestecker, Karel;
- Annemans, Lieven;
- De Bruycker, Aurélie;
- Fonteyne, Valérie;
- Lumen, Nicolaas;
- Ameye, Filip;
- Billiet, Ignace;
- Joniau, Steven;
- De Meerleer, Gert;
- Ost, Piet;
- Bultijnck, Renée
Publication type:
Article
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy.
Published in:
BJU International, 2017, v. 120, n. 6, p. 815, doi. 10.1111/bju.13938
By:
- De Bruycker, Aurélie;
- Lambert, Bieke;
- Claeys, Tom;
- Delrue, Louke;
- Mbah, Chamberlain;
- De Meerleer, Gert;
- Villeirs, Geert;
- De Vos, Filip;
- De Man, Kathia;
- Decaestecker, Karel;
- Fonteyne, Valérie;
- Lumen, Nicolaas;
- Ameye, Filip;
- Billiet, Ignace;
- Joniau, Steven;
- Vanhaverbeke, Friedl;
- Duthoy, Wim;
- Ost, Piet
Publication type:
Article
Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients.
Published in:
Diagnostics (2075-4418), 2017, v. 7, n. 4, p. 56, doi. 10.3390/diagnostics7040056
By:
- Huysse, Wouter;
- Lecouvet, Frédéric;
- Castellucci, Paolo;
- Ost, Piet;
- Lambrecht, Valerie;
- Artigas, Carlos;
- Marie-Laurence, Denis;
- De Man, Kathia;
- Delrue, Louke;
- Jans, Lennart;
- De Bruycker, Aurélie;
- De Vos, Filip;
- De Meerleer, Gert;
- Decaestecker, Karel;
- Fonteyne, Valerie;
- Lambert, Bieke
Publication type:
Article

Found: 5

Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries.

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.

A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer.

Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy.

Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients.